Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 4,234 | 3,956 | 3,636 | 3,863 | 2,191 |
| Cost of Goods | 6,600 | 3,357 | 3,115 | 3,667 | 2,120 |
| Gross Profit | -2,366 | 599 | 521 | 196 | 100 |
| Operating Expenses | 12,949 | 9,689 | 9,167 | 7,985 | 6,230 |
| Operating Income | -14,715 | -8,733 | -8,531 | -7,122 | -6,039 |
| Interest Expense | 713 | 910 | 676 | 2,481 | 1,390 |
| Other Income | 146 | 135 | 444 | -172 | 389 |
| Pre-tax Income | -15,282 | -9,508 | -8,763 | -9,775 | -7,040 |
| Net Income Continuous | -15,282 | -9,508 | -8,763 | -9,775 | -7,044 |
| Net Income | $-15,282 | $-9,508 | $-8,763 | $-9,775 | $-7,044 |
| EPS Basic Total Ops | -0.60 | -0.55 | -0.51 | -0.98 | -12.27 |
| EPS Basic Continuous Ops | -0.60 | -0.55 | -0.51 | -0.98 | -12.27 |
| EPS Diluted Total Ops | -0.60 | -0.55 | -0.51 | -0.98 | -12.27 |
| EPS Diluted Continuous Ops | -0.60 | -0.55 | -0.51 | -0.98 | -12.27 |
| EBITDA(a) | $-13,383 | $-7,505 | $-7,429 | $-4,911 | $-4,891 |